SCHEMBL31046992

SCHEMBL31046992

N#CCC(=O)Nc1cccc(F)c1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
HSD17B10 Q99714 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ALPL P05186 1/20 0.46
ALPI P09923 1/20 0.46
ALPG P10696 1/20 0.46
SMN1; SMN2 Q16637 5/20 0.43
MAPT P10636 2/20 0.43
POLB P06746 2/20 0.43
GAA P10253 3/20 0.43
HTT P42858 2/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 2/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
MCL1 Q07820 1/20 0.41
TSHR P16473 2/20 0.40
MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11031904 0.87 ALDH1A1 (0.59) ALDH1A1HSD17B10KDM4ESMN1; SMN2MAPT
SCHEMBL11202923 0.81 KMT2A (0.49) ALDH1A1HSD17B10KDM4EHTTCA12
SCHEMBL9442187 0.81 ALDH1A1 (0.68) ALDH1A1HSD17B10KDM4ESMN1; SMN2GAA
SCHEMBL2187600 0.78 ALPL (0.49) ALDH1A1ALPLALPIALPGSMN1; SMN2
SCHEMBL2795240 0.78 ALDH1A1 (0.49) ALDH1A1KDM4EALPLALPIALPG
SCHEMBL3949534 0.77 ALDH1A1 (0.51) ALDH1A1ALPLALPIALPGSMN1; SMN2
SCHEMBL4633649 0.75 ALPL (0.47) ALDH1A1ALPLALPIALPGSMN1; SMN2
SCHEMBL27136388 0.75 SMN1; SMN2 (0.51) ALDH1A1KDM4EALPLALPIALPG
SCHEMBL2264097 0.75 MCL1 (0.54) ALDH1A1HSD17B10KDM4ESMN1; SMN2GAA
SCHEMBL5481312 0.75 ALDH1A1 (0.60) ALDH1A1HSD17B10KDM4ESMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024194607-A1 PYRIMIDO[4,5-B][1,5]NAPHTHYRIDINE-4,5(3H,10H)-DIONE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH PTC MUTATIONS, SUCH AS E.G. CANCER Tay Therapeutics Limited (GB) 2024-09-26 WO disclosed